Filing Date |
T Date |
Ticker |
Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
#f |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
9/30/24 16:53 | 9/26/24 | OTLK | Health | BioPrd | Biological Products, (No Diag | Kenyon Lawrence A | NJ | DO | CFO | 1 | P | 28 | 5.69 | 0 | 5 | 529 | 6 | D | ||||||||||||||
4/17/24 20:21 | 4/15/24 | OTLK | Health | BioPrd | Biological Products, (No Diag | Syntone Ventures LLC | NC | T | 1 | P.d | 0 | 0.00 | 0 | 714 | 72 | 1,705 | D | |||||||||||||||
3/29/24 10:39 | 3/28/24 | OTLK | Health | BioPrd | Biological Products, (No Diag | Haddadin Yezan Munther | NJ | D | 1 | P | 22 | 11.82 | 0 | 2 | 59 | 5 | D | |||||||||||||||
3/11/24 16:43 | 3/7/24 | OTLK | Health | BioPrd | Biological Products, (No Diag | Evanson Jeff | NJ | O | Chief Co | 1 | P | 26 | 0.4200 | 0 | 62 | 8 | 808 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |